{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T11:37:19Z","timestamp":1780054639475,"version":"3.54.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Med. Toxicol."],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s13181-019-00720-3","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T14:02:53Z","timestamp":1561989773000},"page":"255-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Does Lidocaine Cause False Positive Results on Cocaine Urine Drug Screen?"],"prefix":"10.1007","volume":"15","author":[{"given":"Eungjae","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian Patrick","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Salehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim P.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D.","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Schindler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent W.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"issue":"16","key":"720_CR1","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.2146\/ajhp090477","volume":"67","author":"NC Brahm","year":"2010","unstructured":"Brahm NC, Yeager LL, Fox MD, Farmer KC, Palmer TA. Commonly prescribed medications and potential false-positive urine drug screens. Am J Health Syst Pharm. 2010;67(16):1344\u201350. https:\/\/doi.org\/10.2146\/ajhp090477 .","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"720_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/clinchem\/34.2.324","volume":"34","author":"I Sunshine","year":"1988","unstructured":"Sunshine I. Preliminary tests for drugs of abuse. Clin Chem. 1988;34(2):331\u20134.","journal-title":"Clin Chem"},{"issue":"Pt 2","key":"720_CR3","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/000456328902600215","volume":"26","author":"D Simpson","year":"1989","unstructured":"Simpson D, Jarvie DR, Heyworth R. An evaluation of six methods for the detection of drugs of abuse in urine. Ann Clin Biochem. 1989;26(Pt 2):172\u201381. https:\/\/doi.org\/10.1177\/000456328902600215 .","journal-title":"Ann Clin Biochem"},{"key":"720_CR4","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780199637119.001.0001","volume-title":"Immunoassays. A practical approach","author":"J Gosling","year":"2000","unstructured":"Gosling J. Immunoassays. A practical approach. Oxford: Oxford University Press; 2000."},{"issue":"6","key":"720_CR5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3109\/15563650.2013.801982","volume":"51","author":"A Rengarajan","year":"2013","unstructured":"Rengarajan A, Mullins ME. How often do false-positive phencyclidine urine screens occur with use of common medications? Clin Toxicol (Phila). 2013;51(6):493\u20136. https:\/\/doi.org\/10.3109\/15563650.2013.801982 .","journal-title":"Clin Toxicol (Phila)"},{"issue":"4","key":"720_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1093\/clinchem\/32.4.715","volume":"32","author":"A Sorisky","year":"1986","unstructured":"Sorisky A, Watson DC. Positive diphenhydramine interference in the EMIT-st assay for tricyclic antidepressants in serum. Clin Chem. 1986;32(4):715.","journal-title":"Clin Chem"},{"issue":"1","key":"720_CR7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/clinchem\/48.1.205","volume":"48","author":"A Gagajewski","year":"2002","unstructured":"Gagajewski A, Davis GK, Kloss J, Poch GK, Anderson CJ, Apple FS. False-positive lysergic acid diethylamide immunoassay screen associated with fentanyl medication. Clin Chem. 2002;48(1):205\u20136.","journal-title":"Clin Chem"},{"issue":"7","key":"720_CR8","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jat\/bku075","volume":"38","author":"A Saitman","year":"2014","unstructured":"Saitman A, Park HD, Fitzgerald RL. False-positive interferences of common urine drug screen immunoassays: a review. J Anal Toxicol. 2014;38(7):387\u201396. https:\/\/doi.org\/10.1093\/jat\/bku075 .","journal-title":"J Anal Toxicol"},{"key":"720_CR9","unstructured":"National Institue on Drug Abuse. Cocaine. 2018. National Institute on Drug Abuse website. https:\/\/www.drugabuse.gov\/publications\/drugfacts\/cocaine . Accessed 01\/04\/2019."},{"issue":"5","key":"720_CR10","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/00007691-199810000-00019","volume":"20","author":"EJ Cone","year":"1998","unstructured":"Cone EJ, Tsadik A, Oyler J, Darwin WD. Cocaine metabolism and urinary excretion after different routes of administration. Ther Drug Monit. 1998;20(5):556\u201360.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"720_CR11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/j.1875-9114.1997.tb03059.x","volume":"17","author":"KD Eskridge","year":"1997","unstructured":"Eskridge KD, Guthrie SK. Clinical issues associated with urine testing of substances of abuse. Pharmacotherapy. 1997;17(3):497\u2013510.","journal-title":"Pharmacotherapy."},{"issue":"2","key":"720_CR12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1124\/jpet.113.206383","volume":"347","author":"NJ Connors","year":"2013","unstructured":"Connors NJ, Hoffman RS. Experimental treatments for cocaine toxicity: a difficult transition to the bedside. J Pharmacol Exp Ther. 2013;347(2):251\u20137. https:\/\/doi.org\/10.1124\/jpet.113.206383 .","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"720_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/jat\/32.4.315","volume":"32","author":"GM Reisfield","year":"2008","unstructured":"Reisfield GM, Haddad J, Wilson GR, Johannsen LM, Voorhees KL, Chronister CW, et al. Failure of amoxicillin to produce false-positive urine screens for cocaine metabolite. J Anal Toxicol. 2008;32(4):315\u20138.","journal-title":"J Anal Toxicol"},{"issue":"6 Pt 1","key":"720_CR14","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/clinchem\/48.6.958","volume":"48","author":"K Hickey","year":"2002","unstructured":"Hickey K, Seliem R, Shields J, McKee A, Nichols JH. A positive drug test in the pain management patient: deception or herbal cross-reactivity? Clin Chem. 2002;48(6 Pt 1):958\u201360.","journal-title":"Clin Chem"},{"issue":"10","key":"720_CR15","first-page":"893","volume":"5","author":"EC Vincent","year":"2006","unstructured":"Vincent EC, Zebelman A, Goodwin C. What common substances can cause false positives on urine screens for drugs of abuse? J Fam Pract. 2006;5(10):893\u20137.","journal-title":"J Fam Pract"},{"issue":"6","key":"720_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/01.mej.0000224424.36444.19","volume":"13","author":"SS Mazor","year":"2006","unstructured":"Mazor SS, Mycyk MB, Wills BK, Brace LD, Gussow L, Erickson T. Coca tea consumption causes positive urine cocaine assay. Eur J Emerg Med. 2006;13(6):340\u20131. https:\/\/doi.org\/10.1097\/01.mej.0000224424.36444.19 .","journal-title":"Eur J Emerg Med"},{"issue":"3","key":"720_CR17","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.jpainsymman.2003.07.008","volume":"27","author":"HA Heit","year":"2004","unstructured":"Heit HA, Gourlay DL. Urine drug testing in pain medicine. J Pain Symptom Manag. 2004;27(3):260\u20137. https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.07.008 .","journal-title":"J Pain Symptom Manag"},{"key":"720_CR18","unstructured":"Drugs.com Forum. Thread: can lidocaine (patch) cause a false positive for cocaine on a drug test? https:\/\/www.drugs.com\/answers\/can-lidocaine-patch-cause-a-false-positive-for-340237.html . Accessed 01\/04\/2019."},{"key":"720_CR19","unstructured":"The Straight Dope Forum. Thread: lidocaine showing up as a false positive for cocaine. http:\/\/boards.straightdope.com\/sdmb\/showthread.php?t=210222 . Accessed 01\/04\/2019."},{"key":"720_CR20","unstructured":"MedsChat- The People\u2019s Medicine Community Forum. Thread: can lidocaine cause a positive drug test? http:\/\/www.medschat.com\/Discuss\/Can-Lidocaine-Cause-A-Positive-Drug-Test-240458.htm . Accessed 01\/04\/2019."},{"issue":"47","key":"720_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1021\/cen-v087n047.p004","volume":"87","author":"RM White","year":"2009","unstructured":"White RM. Drug testing and \u2018Caine\u2019 drugs. Chem Eng News. 2009;87(47):4.","journal-title":"Chem Eng News"},{"issue":"11","key":"720_CR22","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/S0196-0644(88)80078-7","volume":"17","author":"M Shannon","year":"1988","unstructured":"Shannon M. Clinical toxicity of cocaine adulterants. Ann Emerg Med. 1988;17(11):1243\u20137.","journal-title":"Ann Emerg Med"},{"issue":"4","key":"720_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/02791072.1982.10524303","volume":"14","author":"RK Siegel","year":"1982","unstructured":"Siegel RK. Cocaine smoking. J Psychoactive Drugs. 1982;14(4):271\u2013359. https:\/\/doi.org\/10.1080\/02791072.1982.10524303 .","journal-title":"J Psychoactive Drugs"},{"issue":"3","key":"720_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0379-0738(98)00102-9","volume":"95","author":"N Fucci","year":"1998","unstructured":"Fucci N, De Giovanni N. Adulterants encountered in the illicit cocaine market. Forensic Sci Int. 1998;95(3):247\u201352.","journal-title":"Forensic Sci Int"},{"issue":"19","key":"720_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S0168-8278(05)80187-4","volume":"1","author":"YS Huang","year":"1993","unstructured":"Huang YS, Lee SD, Deng JF, Wu JC, Lu RH, Lin YF, et al. Measuring lidocaine metabolite\u2014monoethylglycinexylidide as a quantitative index of hepatic function in adults with chronic hepatitis and cirrhosis. J Hepatol. 1993;1(19):140\u20137.","journal-title":"J Hepatol"},{"issue":"4","key":"720_CR26","first-page":"167","volume":"26","author":"SB Bhise","year":"2007","unstructured":"Bhise SB, Dias RJ. Monoethylglycinexylidide (MEGX) as a liver function test in cirrhosis. Indian J Gastroenterol. 2007;26(4):167\u20139.","journal-title":"Indian J Gastroenterol"},{"issue":"19","key":"720_CR27","first-page":"154","volume":"45","author":"R Testa","year":"1989","unstructured":"Testa R, Campo N, Caglieris S, Risso D, Alvarez S, Arzani L, et al. Lidocaine elimination and monoethylglycinexylidide formation in patients with chronic hepatitis or cirrhosis. Hepato-gastroenterology. 1989;45(19):154\u20139.","journal-title":"Hepato-gastroenterology."},{"key":"720_CR28","unstructured":"Beckman Coulter I. Emit II Plus - Cocaine Metabolite Assay Product Summary 2010."},{"issue":"4","key":"720_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1520\/JFS13836J","volume":"40","author":"AH Wu","year":"1995","unstructured":"Wu AH, Forte E, Casella G, Sun K, Hemphill G, Foery R, et al. CEDIA for screening drugs of abuse in urine and the effect of adulterants. J Forensic Sci. 1995;40(4):614\u20138.","journal-title":"J Forensic Sci"},{"key":"720_CR30","unstructured":"Substance Abuse and Mental Health Services Administration. Guidelines for analyte cutoffs. 2010. https:\/\/www.samhsa.gov\/sites\/default\/files\/workplace\/2010GuidelinesAnalytesCutoffs.pdf .\u00a0Accessed 9 Feb 2019."},{"issue":"4","key":"720_CR31","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1520\/JFS12890J","volume":"35","author":"EJ Cone","year":"1990","unstructured":"Cone EJ, Yousefnejad D, Dickerson SL. Validity testing of commercial urine cocaine metabolite assays: IV. Evaluation of the EMIT d.a.u. cocaine metabolite assay in a quantitative mode for detection of cocaine metabolite. J Forensic Sci. 1990;35(4):786\u201391.","journal-title":"J Forensic Sci"},{"issue":"8","key":"720_CR32","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","volume":"147","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med. 2007;147(8):573\u20137.","journal-title":"Ann Intern Med"},{"key":"720_CR33","doi-asserted-by":"crossref","unstructured":"Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Stat Sci. 2001;16(2):101\u201317.","DOI":"10.1214\/ss\/1009213286"},{"issue":"2","key":"720_CR34","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1600-0536.2008.01366.x","volume":"59","author":"JP Thyssen","year":"2008","unstructured":"Thyssen JP, Menne T, Elberling J, Plaschke P, Johansen JD. Hypersensitivity to local anaesthetics--update and proposal of evaluation algorithm. Contact Dermatitis. 2008;59(2):69\u201378. https:\/\/doi.org\/10.1111\/j.1600-0536.2008.01366.x .","journal-title":"Contact Dermatitis"}],"container-title":["Journal of Medical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00720-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13181-019-00720-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13181-019-00720-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T13:14:44Z","timestamp":1721481284000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13181-019-00720-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1007\/s13181-019-00720-3","relation":{},"ISSN":["1556-9039","1937-6995"],"issn-type":[{"value":"1556-9039","type":"print"},{"value":"1937-6995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"19 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The manuscript was written in accordance with the Strengthening The Reporting of Observational Studies in Epidemiology (STROBE) guidelines [] and the study was approved by the Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"The view(s) expressed herein are those of the author(s) and do not reflect the official policy or position of the US Air Force Office of the Surgeon General, the Department of the Air Force, the Department of Defense, or the US Government.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}